Keiichi Murakami
Chuo, 8608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer.
Journal: Molecular cancer
Published: November 28, 2017
Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients.
Journal: Translational oncology
Published: April 06, 2017
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients.
Journal: BMC cancer
Published: July 31, 2016
Docetaxel and cyclophosphamide chemotherapy induced radiation recall phenomenon in a postoperative breast cancer patient: a case report.
Journal: International cancer conference journal
Published: February 25, 2016
A case of estrogen receptor-positive metastatic breast cancer in a postmenopausal woman treated with ethinyl estradiol
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 17, 2013
High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Journal: Breast cancer (Tokyo, Japan)
Published: June 21, 2012
Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.
Journal: Annals of surgical oncology
Published: January 10, 2012
Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
Journal: Breast cancer (Tokyo, Japan)
Published: October 31, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026